Answer questions at the heart of your business, questions that in-house analysis may have left unchallenged.
Evaluate Custom Solutions
Corporate Strategy Teams
An external industry perspective to complement your views on the market, competition, and your company's strategic direction.
Find out how a major global pharma gained an external perspective on market trends to support a key Executive Team strategy session.
R&D Strategy & Portfolio Planning
An objective third party to validate if you are making the right choice for your product portfolio.
Find out how a Japanese pharma company benchmarked the R&D productivity of peer companies for insight into potential patterns and drivers.
Digital and Data Science Teams
Feed industry-leading Evaluate commercial intelligence directly into your internal tools, systems and workflows via data feeds and APIs.
Find out how a major US pharma created a live M&A target screening tool by integrating Evaluate data into a data visualization dashboard.
COMMERCIAL OPS, PRICING & FORECASTING
Customised epidemiology research, forecast modelling, and pricing analysis to inform your product strategy and tactical planning.
Find out how a pharma commercial and finance group established a standard forecasting methodology across an entire business.
Business Development & Licensing
Expedite your search and screen efforts to partner, license and sell assets you would otherwise miss.
Find out how a mid-sized pharma BD&L team outsourced their search and screen efforts for a shortlist of assets with potential for licensing.
“ Evaluate Custom Solutions paid careful attention to our report needs, and the after-care service was excellent, so our level of satisfaction was extremely high. It was one of the best services that I have experienced so far. ”
Motomu Himori, Specialist, Chugai Pharmaceutical Co., Ltd.
“ I really could not do my job without Evaluate data. You guys make me look good all the time. ”
Business Development & Licensing, Large Pharmaceutical
Evaluate Omnium
How we can help you
Evaluate Omnium
Evaluate Omnium is the first and only solution on the market that provides a complete, dynamic view of development risk and commercial return, while also addressing the information gaps that lead to unproductive portfolio investments. The result is 4 times greater accuracy when predicting which Phase I assets will reach the market and a 21% accuracy improvement when predicting commercial potential for Phase I assets, compared to calculations made based on industry average benchmarks.